JINGXIN(SZ:002020) Xin Lang Zheng Quan·2025-10-14 03:12Core Viewpoint - Jingxin Pharmaceutical's stock has experienced fluctuations, with a year-to-date increase of 51.26% but a recent decline in the last five and twenty trading days [1][2]. Financial Performance - For the first half of 2025, Jingxin Pharmaceutical reported revenue of 2.017 billion yuan, a year-on-year decrease of 6.20%, and a net profit attributable to shareholders of 388 million yuan, down 3.54% [2]. - The company has distributed a total of 2.11 billion yuan in dividends since its A-share listing, with 801 million yuan distributed over the past three years [3]. Stock Market Activity - As of October 14, the stock price was 18.86 yuan per share, with a market capitalization of 16.239 billion yuan. The trading volume was 111 million yuan, with a turnover rate of 0.80% [1]. - The stock has appeared on the "龙虎榜" (a trading board for stocks with significant trading activity) once this year, with a net buy of 111 million yuan on July 4 [1]. Shareholder Information - As of June 30, 2025, the number of shareholders was 25,700, a slight decrease of 0.11%, with an average of 28,196 circulating shares per shareholder, an increase of 0.11% [2]. - The fifth-largest circulating shareholder is Hong Kong Central Clearing Limited, holding 9.6492 million shares, a decrease of 15.3917 million shares from the previous period [3].